Vinay Puduvalli

Vinay Puduvalli, MBBS

Physician

Make an Appointment

Overall Patient Satisfaction Rating

stars
4.9 out of 5
157
Reviews
11
Comments

Gender

Male

Biography


I'm a neuro-oncologist with expertise in caring for patients with brain and spine tumors. I was named to the Castle Connolly list of “America's Top Doctors” from 2013-2019.

By affecting the nervous system, which is the core of our identity, personality and function, these tumors not only limit life span but also deeply impact your quality of life. To me, they represent a challenge we must overcome through clinical expertise, compassion and research.

I believe in combining the latest advances in cancer treatment with an individualized approach to each person in order to change a patient’s outcome from this disease. We know that no brain cancer is routine, and I work to develop specific treatment plans for each patient and each tumor, providing the right treatment at the right time. I also provide such care for my patients in a comprehensive, compassionate manner because I believe that preserving a person’s dignity and quality of life is as important as increasing their life span

I found my calling in combining the best of patient care and cutting- edge research in order to build the next generation of treatments for this disease. Along with the team of expert clinicians in our Brain and Spine Tumor center, we are working to make definitive and lasting improvement in the lives of our patients.

I find my inspiration in passionately working with our team of accomplished faculty and staff at The Ohio State University Comprehensive Cancer Center – James Cancer Hospital and Solove Research Institute to bring the most advanced treatment for our patients with brain and spine tumors. I strongly believe that together we can make a real difference in the lives of our patients.

Education and Background

Education

Bangalore Medical College & Research Institute

Bengaluru, India

Residencies

University of Texas Health Sciences Center

Houston, United States

Fellowship

Neuro-Oncology

The University of Texas MD Anderson Cancer Center

HOUSTON, TX

Psychiatry

National Institute of Mental Health and Neuroscience

Bangalore, India

Board Certifications

American Board of Psychiatry & Neurology (Subspecialty: Neurology)

Academic Department

Department of Neurology


Consulting and Related Relationships

At The Ohio State University Wexner Medical Center, we support a faculty member’s research and consulting in collaboration with medical device, research and/or drug companies because a faculty member’s expertise can guide important advancements in the practice of medicine and improve patient care. In order to provide effective management of these relationships, the university requires annual disclosures from all faculty members with external interests related to their university responsibilities. As of 12/20/2018, Dr. Puduvalli has reported relationships with the companies or entities listed below. If you have questions about the relationships listed below, please ask the faculty member. If you have questions about how these relationships are monitored by The Ohio State University Wexner Medical Center, please contact our Compliance Office.

Gilead Sciences, Inc.

Orbus

SK Lifesciences

ZIOPHARM ONCOLOGY INC.

Reviews

Patient Satisfaction Review

The overall patient satisfaction rating is an average of all patient responses to the five questions gathered from the Outpatient Oncology survey, developed by Press Ganey Associates for use in oncology clinics across the country. On behalf of The James, Press Ganey administers the survey to patients who see our providers in an outpatient clinic office. For additional information about the patient satisfaction survey, please visit our Patient Satisfaction Survey page

The comments are submitted by patients and reflect their view and opinions. The comments are not endorsed by and do not necessarily reflect the views of The James.

Overall Ratings (out of 157 reviews)
stars
4.9 out of 5
Kept you informed about your condition and treatment

4.9/ 5

Amount of time spent with you

4.8/ 5

Concern for your questions and issues

4.9/ 5

Skill and knowledge

4.9/ 5

Overall quality of care

4.9/ 5

Patient Comments (11 total comments)

stars
Reviewed: 9/10/2019

Dr. Pudavalli is always very thorough and informative. Every appointment he teaches me something I didn't know. He is so encouraging. He is an amazing person!

stars
Reviewed: 8/26/2019

Dr. Puduvalli is very kind, thorough, and takes his time with me.

stars
Reviewed: 6/30/2019

I felt I was not in this situation alone.

stars
Reviewed: 5/28/2019

Love the way the doctor shows & explains things!

stars
Reviewed: 5/17/2019

Dr. Puduvalli, and anyone he has joining us during the visit, demonstrate preparedness and awareness of my health history. He listens and explains things with respect and sincerity. He is skilled at putting me at ease and we never feel rushed. He is also keenly aware of the impact surgery had on my cognition and closely monitors any changes.

stars
Reviewed: 5/15/2019

Dr. Pudavalli is an incredible teacher. He uses our time together to teach me about my disease. He listens and the explains.

stars
Reviewed: 3/31/2019

cannot say enough good about Dr. Puduvalli and the staff !!

stars
Reviewed: 3/24/2019

Doctor went above and beyond in explaining and confirming my condition/diagnosis and the plan of care and way forward.

stars
Reviewed: 2/22/2019

Dr. is very willing to explain and answer any questions that we have about what is happening with the treatment and follow ups.

stars
Reviewed: 2/15/2019

I've been blessed to be a patient of Dr. Pudavali. He is kind, personable and is an excellent physician with wonderful bedside manner.

Publications

HSP90 inhibition depletes DNA repair proteins to sensitize acute myelogenous leukemia to nucleoside analog chemotherapeutics.

Lai TH, Mitchell S, Wu PJ, Orwick S, Liu C, Ravikrishnan J, Woyach J, Mims A, Plunkett W, Puduvalli VK, Byrd JC, Lapalombella R, Sampath D

Leuk Lymphoma in press

2/18/2019

Selective targeting of NAMPT by KPT-9274 in acute myeloid leukemia.

Mitchell SR, Larkin K, Grieselhuber NR, Lai TH, Cannon M, Orwick S, Sharma P, Asemelash Y, Zhang P, Goettl VM, Beaver L, Mims A, Puduvalli VK, Blachly JS, Lehman A, Harrington B, Henderson S, Breitbach JT, Williams KE, Dong S, Baloglu E, Senapedis W, Kirschner K, Sampath D, Lapalombella R, Byrd JC

Blood Adv 3

2/12/2019

Clinical Trials | Lead

OSU-17310

OSU-18290

ALLIANCE-N0577

Related Videos

Care Philosophy video
Dr. Puduvalli's Research
Back to Find a Doctor Search

Make an Appointment

800-293-5066

Please enter a keyword (i.e. Name, Cancer Type) or choose a Principle Investigator

OR

Please enter a keyword (i.e. Name, Location) or choose a Cancer Type

OR